Nonmelanoma skin cancer and risk of all-cause and cancer-related mortality: a systematic review
Some reports suggest that a history of nonmelanoma skin cancer (NMSC) may be associated with increased mortality. NMSCs have very low fatality rates, but the high prevalence of NMSC elevates the importance of the possibility of associated subsequent mortality from other causes. The variable methods and findings of existing studies leave the significance of these results uncertain. To provide clarity, we conducted a systematic review to characterize the evidence on the associations of NMSC with: (1) all-cause mortality, (2) cancer-specific mortality, and (3) cancer survival. Bibliographic databases were searched through February 2016. Cohort studies published in English were included if adequate data were provided to estimate mortality ratios in patients with-versus-without NMSC. Data were abstracted from the total of eight studies from independent data sources that met inclusion criteria (n = 3 for all-cause mortality, n = 2 for cancer-specific mortality, and n = 5 for cancer survival). For all-cause mortality, a significant increased risk was observed for patients with a history of squamous cell carcinoma (SCC) (mortality ratio estimates (MR) 1.25 and 1.30), whereas no increased risk was observed for patients with a history of basal cell carcinoma (BCC) (MRs 0.96 and 0.97). Based on one study, the association with cancer-specific mortality was stronger for SCC (MR 2.17) than BCC (MR 1.15). Across multiple types of cancer both SCC and BCC tended to be associated with poorer survival from second primary malignancies. Multiple studies support an association between NMSC and fatal outcomes; the associations tend to be more potent for SCC than BCC. Additional investigation is needed to more precisely characterize these associations and elucidate potential underlying mechanisms.
KeywordsNonmelanoma skin cancer Keratinocyte carcinoma Mortality Survival Fatality Epidemiology Systematic review Neoplasms
Compliance with ethical standards
Conflict of interest
The authors have no conflicts of interest to declare.
This study was supported by funding from the National Cancer Institute Cancer Center Support Grant (P30 CA38313) to the Hollings Cancer Center, Medical University of South Carolina.
No original data were collected for this systematic review, so this research did not require ethical approval.
- 20.Tatebe K. (2005) Combining multiple averaged data points and their errors. White Paper. Retrieved from http:// isi.ssl.berkeley.edu/~tatebe/ whitepapers/Combining%20Errors.pdfGoogle Scholar
- 24.Ogdie A, Yu Y, Haynes K, Love TJ, Maliha S, Jiang Y, Troxel AB, Hennessy S, Kimmel SE, Margolis DJ, Choi H, Mehta NN, Gelfand JM (2015) Risk of major cardiovascular events in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a population-based cohort study. Ann Rheum Dis 74(2):326–332CrossRefPubMedGoogle Scholar
- 25.Karagas M, Weinstock M, Nelson H (2006) Keratinocyte carcinomas (basal and squamous cell carcinomas of the skin). In: Cancer epidemiology and prevention. 3rd edition. Oxford University Press, New York p. 1230–1250Google Scholar
- 34.Alberg AJ, Shopland DR, Cummings KM (2014) The 2014 Surgeon General’s report: commemorating the 50th Anniversary of the 1964 Report of the Advisory Committee to the US Surgeon General and updating the evidence on the health consequences of cigarette smoking. Am J Epidemiol 179(4):403–412CrossRefPubMedPubMedCentralGoogle Scholar
- 38.U.S. Department of Health and Human Services (2014) The health consequences of smoking: A report of the Surgeon General. Atlanta, GA: U.S. Dept. of Health and Human Services, Centers for Disease Control and Prevention, Office on Smoking and HealthGoogle Scholar